Juneyao Grand Healthy Drinks (605388)
Search documents
食品饮料行业双周报:白酒短期承压,大众品关注高景气赛道-20250609
Guoyuan Securities· 2025-06-09 13:16
Investment Rating - The report maintains a "Recommendation" rating for the food and beverage industry, indicating that the industry index is expected to outperform the benchmark index by more than 10% [5]. Core Insights - The food and beverage sector in A-shares has seen a decline of 2.12% over the past two weeks, underperforming the Shanghai Composite Index by 3.22 percentage points [2][14]. - Within the sector, soft drinks (+9.45%), snacks (+5.48%), and other alcoholic beverages (+4.98%) have shown the highest gains, while dairy products (-3.81%), liquor (-3.64%), and fermented seasoning products (-1.26%) have experienced the largest declines [2][14]. - Notable individual stock performances include Junyao Health (+72.44%), Hainan Coconut Island (+20.26%), and Miaokelando (+19.95%) leading in gains, while Wufangzhai (-10.35%), ST Jiajia (-6.92%), and Shanxi Fenjiu (-5.41%) faced the largest losses [2][14]. Summary by Sections Market Review - The food and beverage industry in A-shares has underperformed compared to major indices, with a year-to-date decline of 2.57% [14]. - The report highlights the performance of various sub-sectors, with soft drinks and snacks showing resilience while liquor and dairy face challenges [2][14]. Key Data Tracking - The report provides pricing data for key products, such as the price of Feitian Moutai at 2,130 RMB for original boxes and 2,050 RMB for bulk, reflecting a decrease of 25 RMB and 50 RMB respectively over two weeks [3][29]. - The average price of fresh milk in major production areas is reported at 3.06 RMB per kilogram, down 8.4% year-on-year [36]. Key Events Tracking - The report notes that the food manufacturing sector's profit increased by 1.1% year-on-year in the first four months of 2025, with total revenue reaching 713.58 billion RMB [4][55]. - Performance in the e-commerce space during the Tmall 618 event shows strong sales for brands like Three Squirrels and Good Products Store [4][55]. Investment Recommendations - For the liquor segment, the report suggests focusing on high-end brands with strong market positions, such as Guizhou Moutai and Wuliangye, while also considering regional leaders with favorable competitive dynamics [10][56]. - In the broader consumer goods category, the report highlights the rising popularity of yellow wine and the seasonal uptick in beer consumption, alongside strong performance in snack foods and energy drinks [10][56].
均瑶健康:监事陈艳秋于6月6日根据减持计划减持了5700股公司股票
news flash· 2025-06-09 12:09
智通财经6月9日电,均瑶健康(605388.SH)发布异动公告,公司于2025年2月28日披露了《湖北均瑶大健 康饮品股份有限公司部分董监高集中竞价减持股份计划公告》。公司监事陈艳秋于本次股票交易异常波 动期间内即2025年6月6日根据减持计划减持了5700股公司股票。经公司核实,公司控股股东、实际控制 人及其一致行动人,以及公司其他董事、监事、高级管理人员在公司本次股票交易异常波动期间不存在 买卖公司股票的情况。 均瑶健康:监事陈艳秋于6月6日根据减持计划减持了5700股公司股票 ...
“常温乳酸菌第一股”受罚背后:上市五年净利润首度亏损 押宝益生菌难掩业绩颓势
Mei Ri Jing Ji Xin Wen· 2025-06-07 13:49
Core Viewpoint - Junyao Health, known as the "first stock of ambient lactic acid bacteria," has recently faced penalties for failing to timely announce a profit warning for its 2024 annual performance, marking its first annual loss since its listing in 2020 [1][4][5]. Financial Performance - In 2024, Junyao Health reported a revenue of 1.458 billion yuan, a year-on-year decline of 10.77% [6]. - The company recorded a net profit loss attributable to shareholders of 29.1164 million yuan for 2024, primarily due to impairment provisions totaling 3.643 million yuan for goodwill, 1.276 million yuan for inventory, and 3.660 million yuan for credit losses [4][5]. - In the first quarter of 2025, the company achieved a revenue of 401 million yuan, a year-on-year increase of 1.41%, but the net profit attributable to shareholders decreased by 58.29% to 10.91 million yuan [6]. Stock Performance - Despite the poor financial performance, Junyao Health's stock price surged over 70% in less than two weeks, from 6.35 yuan per share to 10.95 yuan per share [2][7]. Business Strategy and Challenges - The company has been diversifying into new business areas such as bottled water, probiotics, and supply chain management, but these efforts have not yet yielded significant results [9][11]. - The probiotics segment, which is a key focus for the company, has faced challenges including low industry entry barriers, intense price competition, and changing consumer preferences towards low-sugar products [10]. - The supply chain business, acquired in 2022, failed to meet its revenue and profit commitments, contributing to the company's financial difficulties [11].
均瑶健康(605388) - 湖北均瑶大健康饮品股份有限公司关于公司及相关责任人收到湖北证监局警示函的公告
2025-06-06 10:16
警示函的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 证券代码:605388 证券简称:均瑶健康 公告编号:2025-032 湖北均瑶大健康饮品股份有限公司 关于公司及相关责任人收到湖北证监局 (证监会令第 182 号)第四条、第五十一条第二款和第三款的规定履行勤勉尽 责义务,对公司上述违规行为负有主要责任。 根据《上市公司信息披露管理办法》(证监会令第 182 号)第五十二条的规 定,我局决定对湖北均瑶大健康饮品股份有限公司、王均豪、俞巍、崔鹏、郭沁 采取出具警示函的行政监管措施,并记入证券期货市场诚信档案。公司及相关责 任人应充分吸取教训,加强证券法律法规学习,杜绝此类行为再次发生。 如果对本监督管理措施不服,可以在收到本决定书之日起 60 日内向中国证 券监督管理委员会提出行政复议申请;也可以在收到本决定书之日起 6 个月内向 有管辖权的人民法院提起诉讼。复议与诉讼期间,上述监督管理措施不停止执 行。" 二、相关情况说明 湖北均瑶大健康饮品股份有限公司(以下简称"公司")近日收到中国证券 监督管理委员会湖北监管局 ...
均瑶健康:收到湖北证监局警示函
news flash· 2025-06-06 09:48
均瑶健康(605388)公告,公司近日收到湖北证监局下发的《警示函》,指出公司存在未按规定披露 2024年度业绩预告的违规事实。2024年归属于上市公司股东净利润为-2911.64万元。公司董事长王均 豪、总经理俞巍、财务总监崔鹏、董事会秘书郭沁因未履行勤勉尽责义务,对违规行为负有主要责任。 湖北证监局决定对公司及相关责任人采取出具警示函的行政监管措施,并记入证券期货市场诚信档案。 公司及相关责任人将加强证券法律法规学习,提高规范意识,避免类似问题再次发生。本次行政监管措 施不会影响公司正常的生产经营活动。 ...
乳业概念下跌1.44%,13股主力资金净流出超千万元
Zheng Quan Shi Bao Wang· 2025-06-06 09:01
Group 1 - The dairy sector experienced a decline of 1.44% as of the market close on June 6, ranking among the top losers in the concept sector [1][2] - Major companies within the dairy sector that saw significant declines include Lihua Foods, New Dairy, and Happy Family, while the top gainers were Junyao Health, *ST Tianshan, and Jinjian Rice Industry, with increases of 5.80%, 1.99%, and 0.59% respectively [1][2] - The dairy sector faced a net outflow of 379 million yuan from main funds today, with 25 stocks experiencing net outflows, and 13 stocks seeing outflows exceeding 10 million yuan [2][3] Group 2 - The stock with the highest net outflow was Yili Group, which saw a net outflow of 114 million yuan, followed by Junyao Health, Bei Yin Mei, and Yiya Tong with outflows of 53.44 million yuan, 40.58 million yuan, and 36.65 million yuan respectively [2][3] - Conversely, the stocks with the highest net inflows included Jinjian Rice Industry, Guangming Dairy, and Weivi Co., with net inflows of 15.03 million yuan, 11.77 million yuan, and 6.89 million yuan respectively [2][3] - The dairy sector's outflow list highlighted Yili Group with a decline of 1.10%, Junyao Health with an increase of 5.80%, and Bei Yin Mei with a decline of 1.78% [3]
均瑶健康(605388) - 湖北均瑶大健康饮品股份有限公司关于增补公司独立董事的公告
2025-06-05 10:15
苏世彦先生独立董事候选人的任职资格需经上海证券交易所审核无异议后, 提交公司股东大会审议。 二、提名委员会意见 证券代码:605388 证券简称:均瑶健康 公告编号:2025-030 湖北均瑶大健康饮品股份有限公司 关于增补公司独立董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、增补独立董事的基本情况 湖北均瑶大健康饮品股份有限公司(以下简称"公司")于 2025 年 6 月 4 日召开了第五届董事会第十四次会议,审议通过了《关于增补公司独立董事的议 案》。 为保证公司治理结构规范运作,依照《公司法》《公司章程》等相关规定, 经公司董事会提名委员会审查通过,公司董事会同意增补苏世彦先生为公司第五 届董事会独立董事候选人(简历附后),任期自股东大会审议通过之日起至第五 届董事会任期届满为止;并同意在增补苏世彦先生为公司独立董事的议案获得股 东大会审议通过的前提下,增补苏世彦先生担任公司董事会薪酬与考核委员会委 员及提名委员会委员,任期与董事任期一致。 特此公告。 湖北均瑶大健康饮品股份有限公司董事会 2025 年 ...
均瑶健康(605388) - 湖北均瑶大健康饮品股份有限公司关于召开2025年第一次临时股东大会的通知
2025-06-05 10:15
证券代码:605388 证券简称:均瑶健康 公告编号:2025-031 召开的日期时间:2025 年 6 月 25 日 14 点 00 分 召开地点:上海市浦东新区康桥东路 2 弄 1 号楼大会议室 股东大会召开日期:2025年6月25日 本次股东大会采用的网络投票系统:上海证券交易所股东大会网络投票 系统 (一)股东大会类型和届次 2025年第一次临时股东大会 (二)股东大会召集人:董事会 (三)投票方式:本次股东大会所采用的表决方式是现场投票和网络投票相结合的 方式 (五)网络投票的系统、起止日期和投票时间。 网络投票系统:上海证券交易所股东大会网络投票系统 网络投票起止时间:自2025 年 6 月 25 日 湖北均瑶大健康饮品股份有限公司 关于召开2025年第一次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 一、 召开会议的基本情况 (四)现场会议召开的日期、时间和地点 至2025 年 6 月 25 日 采用上海证券交易所网络投票系统,通过交易系统投票平台的投票时间为股 东大会召开当 ...
均瑶健康(605388) - 湖北均瑶大健康饮品股份有限公司第五届董事会第十四次会议决议公告
2025-06-05 10:15
证券代码:605388 证券简称:均瑶健康 公告编号:2025-029 湖北均瑶大健康饮品股份有限公司 鉴于公司独立董事史占中先生在公司连续担任独立董事期限已满六年申请 辞任,公司决定增补第五届董事会独立董事一名。经公司董事长推荐,董事会提 名委员会审查通过,现提名苏世彦先生为公司第五届董事会独立董事候选人,任 期自股东大会审议通过之日起至本届董事会任期届满为止;并同意在增补苏世彦 先生为公司独立董事的议案获得股东大会审议通过的前提下,增补苏世彦先生为 公司董事会薪酬与考核委员会主任委员及提名委员会委员。 苏世彦先生独立董事候选人的任职资格需经上海证券交易所审核无异议后, 提交公司股东大会审议。 1 具体内容详见同日披露于上海证券交易所网站(www.sse.com.cn)的《湖 北均瑶大健康饮品股份有限公司关于增补公司独立董事的公告》(公告编号: 2025-030)。 表决结果:同意:9 票,反对:0 票,弃权:0 票。 第五届董事会第十四次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 ...
千万别踩雷!多只高位股股东拟减持(附股)
Feng Huang Wang Cai Jing· 2025-06-04 10:54
Market Overview - The three major stock indices collectively rose today, with nearly 4,000 stocks increasing in value. Key sectors showing strong performance include brokerage firms and diversified financials, as well as consumer goods and innovative pharmaceuticals [1] - The trading volume in the Shanghai and Shenzhen markets reached 1.15 trillion, indicating no significant increase in trading activity [1] Sector Performance - The beer and soft drink sectors performed well, driven by seasonal demand due to high summer temperatures. Stocks such as 嘉美包装 (Jia Mei Packaging), 乐惠国际 (Le Hui International), and 永顺泰 (Yong Shun Tai) hit their daily limit [1] - Recent trends show a concentration of capital in specific sectors, with significant interest in metals, non-metals, and mining due to rising global risk aversion and domestic resource policies. Key stocks include 紫金矿业 (Zijin Mining) and 赤峰黄金 (Chifeng Jilong Gold Mining) [5] - The electric equipment sector, particularly in renewable energy and nuclear power, is benefiting from technological breakthroughs and policy support. Notable stocks include 宁德时代 (CATL) and 中超控股 (Zhongchao Holdings) [5] Investment Trends - There is a noticeable trend of large funds "hugging" certain stocks, leading to repeated speculation on a few hot topics. This has resulted in significant short-term profit opportunities, although the sustainability of this trend is questionable [6] - High-profile stocks have seen substantial price increases without strong fundamental support, indicating that the market is driven by speculative trading rather than underlying business improvements [5][6] - Recent data shows that some high-performing stocks have experienced insider selling, with executives from 凯因科技 (Kain Technology) and 均瑶健康 (Jun Yao Health) reducing their holdings significantly [7][8]